Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Acadia Healthcare Company Inc (ACHC) vs L3Harris Technologies Inc (LHX) Price & Performance

Acadia Healthcare Company IncTrade
L3Harris Technologies IncTrade

Price performance (Past 24H)

Key statistics

Acadia Healthcare Company Inc vs L3Harris Technologies Inc — how do they compare? Acadia Healthcare Company Inc trades at $31.18 (market cap $2.90B), while L3Harris Technologies Inc trades at $290.16 (market cap $53.26B). The key difference: L3Harris Technologies Inc is far larger — about 18.4× Acadia Healthcare Company Inc's market cap, and L3Harris Technologies Inc pays a 1.75% dividend while Acadia Healthcare Company Inc pays none. Which is the better fit depends on your goals.

ACHCLHX
Market Cap
$2.90B$53.26B
Sector
HealthIndustrials
52-Week High
$35.61$378.48
52-Week Low
$11.68$270.21
Enterprise Value
$5.29B$63.71B
Dividend Yield
1.75%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Acadia Healthcare Company Inc

ACHC trades at $31.70, down 0.25% on the day, with neutral technical indicators and strong analyst support (68% buy ratings). The company has beaten earnings estimates for three consecutive quarters, though profitability remains challenged with a -33.44% net income margin. Recent Q2 2026 results showed revenue of $865.8 million with earnings beating expectations at $0.38 per share.

While facing profitability challenges and ongoing legal investigations, ACHC benefits from strong analyst consensus with a $36.00 price target representing 13.6% upside. The stock offers potential through continued earnings beats and operational improvements, but investors must weigh legal risks against the company's turnaround strategy and behavioral healthcare demand growth.

L3Harris Technologies Inc

LHX trades at $290.66, up 0.32% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong Q2 2026 earnings, beating estimates with revenue up 8% and a record $42 billion backlog. Recent news highlights contract wins, including a U.S. Space Force satellite deal and PAC-3 production expansion, supporting growth prospects. Fundamentals show steady revenue growth to $21.87 billion in 2025 and improving net margins, though valuation ratios like P/E of 28.89 are elevated relative to historical averages.

Outlook is positive with analyst consensus favoring buys (73%) and a $319.33 price target implying ~10% upside. Risks include execution on large contracts, debt levels, and geopolitical dependencies. The stock offers a dividend yield near 1.7%, with cash flow strength supporting shareholder returns amid defense sector tailwinds.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Acadia Healthcare Company Inc

Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.

Read more on ACHC

About L3Harris Technologies Inc

L3Harris Technologies was created in 2019 from the merger of L3 Technologies and Harris, two defense contractors that provide products for the command, control, communications, computers, intelligence, surveillance, and reconnaissance (C4ISR) market. The firm also has smaller operations serving the civil government, particularly the Federal Aviation Administration's communication infrastructure, and produces various avionics for defense and commercial aviation.

Read more on LHX